Theravance Biopharma, Inc. - Ordinary Share $0.00001 Par Value (TBPH)

CUSIP: G8807B106

Q4 2025 13F Holders as of 31 Dec 2025

Security identity
Security type / class
Equity / Ordinary Share $0.00001 Par Value
Shares outstanding
51,428,000
Holder snapshot
Total 13F shares
49,596,822
Share change
+1,071,923
Total reported value
$927,239,298
Put/Call ratio
0%
Reported price per share
$18.71
Number of holders
168
Value change
+$22,675,473
Number of buys
97
Number of sells
63

Security key

G8807B106

Report period

Q4 2025

Institutions

168

Top holders

10

TBPH full security history Ownership snapshot Full 13F holder table Newer quarter: Q1 2026 Previous quarter: Q3 2025 Theravance Biopharma, Inc. SEC filings Theravance Biopharma, Inc. company facts

Broader feeds

Latest 13F filings Latest 13D/G filings Investors directory

Ownership snapshot

Top reported holders of TBPH - Theravance Biopharma, Inc. - Ordinary Share $0.00001 Par Value (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Lead holder
Newtyn Management, LLC
13D/G signal
Newtyn Management, LLC
Evidence rows
15
Latest as of
31 Dec 2025
13D/G 13F 3/4/5 Lead comparable stake: 8.5% 13D/G row: Newtyn Management, LLC Showing 1-6 of 15 holder rows.
Holder Evidence Ownership % Position 12M Net Δ As of
Newtyn Management, LLC
13D/G 13F
Company
13D/G 13F
8.5%
$87,419,000
4,300,000 shares
 -$9,299,003 31 Dec 2025
BlackRock, Inc.
13F 13D/G
Company
13F 13D/G
6.5%
from 13D/G
$59,407,312
4,068,994 shares
 — 30 Sep 2025
Madison Avenue Partners, LP
13F
Company
13F
18%
$138,862,790
9,511,150 shares
 — 30 Sep 2025
Weiss Asset Management LP
13F 3/4/5
Company · 10%+ Owner
13F 3/4/5
14%
$108,873,076
7,457,060 shares
 — 30 Sep 2025
Irenic Capital Management LP
13F
Company
13F
5.4%
$40,309,841
2,760,948 shares
 — 30 Sep 2025
VANGUARD GROUP INC
13F
Company
13F
4.3%
$32,289,097
2,211,582 shares
 — 30 Sep 2025
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q4 2025

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
168
Shares
49,596,822
Rows available
168
Investor Option Weight % Change % Reported value * Price Shares Share Change Activity Report Period

* Reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that failed the local validity check.

Compare Q4 2025 vs Q3 2025 Across Filers

Q3 2025 holders
159
Q4 2025 holders
168
Holder diff
9
Investor Q3 2025 Shares Q4 2025 Shares Share Diff Share Chg % Q3 2025 value Q4 2025 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .